Exit Notice
You are about to leave ClinicalTrials.gov and go to: Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial URL: https://pubmed.ncbi.nlm.nih.gov/21969517/
Click on the link to continue or return to ClinicalTrials.gov Home